what are glp-1 medications Agonists GLP-1 Drugs for Weight Loss:

Importantly, despite the evidence for use of SGLT-2 inhibitors for DKD treatment, they should not be used in patients with type 1 diabetes because of the risk of euglycaemic diabetic ketoacidosis

Research indicating a link between Trulicity and severe side effects: Gastroparesis: Studies show a connection between the use of Trulicity and an increased risk of developing gastroparesis or delayed stomach emptying

GLP-1s are known to have positive cardiovascular effects, and better control of blood glucose levels through GLP-1 treatment has been shown to limit small blood vessel damage that can lead to health complications such as diabetic retinopathy

Patients taking GLP-1 receptor agonists had a 1.15 HR of developing NAION compared to control

GLP-1 receptor agonists are a novel class of pharmacological agents for obesity and T2D